Linetta B. Koppert
Papers
1
Total Citations
6
H-Index
1
About
Linetta B. Koppert is a leading researcher in radiation oncology, with a primary focus on improving treatment outcomes for breast cancer patients through innovative techniques that minimize toxicity. Her key research areas include accelerated partial breast irradiation (APBI), skin toxicity reduction, and the use of spacer technologies in radiotherapy. Dr. Koppert’s most notable contribution is her pioneering work on hyaluronic acid spacer injections to reduce skin toxicity during brachytherapy APBI. Her 2018 study protocol for a randomized controlled trial testing this approach has garnered 6 citations, establishing a foundation for safer, more patient-friendly breast cancer treatments. By addressing the critical risk factor of skin dose, her research directly enhances quality of life for early-stage breast cancer patients. Dr. Koppert’s work is recognized for its translational impact, bridging clinical trial design with practical, toxicity-reducing interventions. Her dedication to refining APBI techniques underscores her commitment to advancing precision oncology and improving patient outcomes in radiation therapy.
Research Focus
Key Achievements
Top Papers
- 1